BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

IMO we are at the point where BTX 1503 is effectively at Phase 3...

  1. 2,763 Posts.
    lightbulb Created with Sketch. 590
    IMO we are at the point where BTX 1503 is effectively at Phase 3 and there is a 2/3 chance of advancing to FDA approval.

    ... which would suggest that the company is a tad undervalued.


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
-0.020(5.26%)
Mkt cap ! $651.6M
Open High Low Value Volume
37.0¢ 37.5¢ 36.0¢ $1.832M 5.001M

Buyers (Bids)

No. Vol. Price($)
30 1023317 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 3589 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.